Reported Reactions

Devices › Electrode, electrocardiograph

Device brand name · Electrode - patch - universal 2 channel

Universal electrode-patch: medical device reports filed with FDA

198 reports name it, 2024–2026. Manufacturer given most often on reports: Braemar Manufacturing. Product code DRX.

198
device reports naming the brand
0% of all MAUDE reports · about 85 a year
160
reports, 12 months to August 2026
34 in the 12 months before
0.5%
classified as malfunction
25.5% across the product code
0.5%
classified as death, as reported
1 reports · not verified by FDA

FDA's MAUDE database holds 198 reports that name the brand "Universal electrode-patch" (electrode - patch - universal 2 channel), received between March 2024 and August 2026; the manufacturer given most often on reports is Braemar Manufacturing. Spellings of one product vary from report to report.

160 reports arrived in the 12 months to August 2026, up 371% from 34 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99%), death (0.5%) and malfunction (0.5%); across all electrode, electrocardiograph reports (product code DRX) death is recorded in 1.5% and malfunction in 25.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are biocompatibility (96.5%), patient device interaction problem (0.5%) and unintended electrical shock (0.5%). The patient problems coded most often are skin inflammation/ irritation, rash and blister. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01326Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 1Apr 2024: 0May 2024: 2Jun 2024: 0Jul 2024: 0Aug 2024: 1Sep 2024: 1Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 2Mar 2025: 1Apr 2025: 2May 2025: 1Jun 2025: 8Jul 2025: 10Aug 2025: 9Sep 2025: 17Oct 2025: 26Nov 2025: 15Dec 2025: 142026Jan 2026: 6Feb 2026: 13Mar 2026: 15Apr 2026: 8May 2026: 10Jun 2026: 9Jul 2026: 12Aug 2026: 15

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0531052024: 520242025: 10520252026: 882026

Event type and report source

Event type, as classified on the report

Death0.5%1
Injury99%196
Malfunction0.5%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%198
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 1,611 reports carrying product code DRX. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Biocompatibility19196.5%13.2%
Patient device interaction problem10.5%0.9%
Unintended electrical shock10.5%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Skin inflammation/ irritation18995.5%
Rashskin rash94.5%
Blistera blister63%
Superficial (first degree) burn42%
Hemorrhage/blood loss/bleeding31.5%
Burn(s)a burn21%
Hypersensitivity/allergic reaction21%
Skin burning sensationburning skin21%
Anaphylactic shocka severe allergic reaction with collapse10.5%
Chest painchest pain10.5%
Painpain, site not specified10.5%
Reaction to medicinal component of device10.5%
Scar tissue10.5%
Skin infection10.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureUniversal electrode-patchProduct code DRXAll MAUDE reports
Reports1981,61126,136,888
Share of that pool—12.3%0%
Classified as death, per 1,000 reports5159
Classified as injury99%57.5%36.2%
Classified as malfunction0.5%25.5%62.3%
Filed by the manufacturer100%68.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DRX

BrandReportsLatest 12 monthsClassified as death
Nissha Medical Technologies1771440%
Skintact245170.4%
Kendall213232.3%
TruWave Disposable Pressure Transducer624670.5%
Conmed900890.2%
Electrodes Onestep Complete26604.9%
Electrodes Onestep Complete Single R Series21781.8%
Valleylab2,0103530.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Universal electrode-patch reports

How many FDA reports name Universal electrode-patch?

198 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 160 in the latest 12 months.

What kinds of events are reported?

injury (99%), death (0.5%) and malfunction (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

biocompatibility (96.5%), patient device interaction problem (0.5%) and unintended electrical shock (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Universal electrode-patch was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.